Mohammad Safarian; Majid Hajifaraji; Monireh Dahri; Naseh Pahlavani; Elyas Nattagh-Eshtivani; Alireza Farsad Naeimi; Anahita Houshiar Rad
Abstract
Introduction: Epidemiologic studies have shown a discrepancy between overweight and puberty processes. This cross-sectional study was aimed to clarify these associations in the Iranian girl population.Methods: A total of 1300 girls aged 11-15 years were randomly selected from Mashhad, in the northeast ...
Read More
Introduction: Epidemiologic studies have shown a discrepancy between overweight and puberty processes. This cross-sectional study was aimed to clarify these associations in the Iranian girl population.Methods: A total of 1300 girls aged 11-15 years were randomly selected from Mashhad, in the northeast of Iran, using a multi-stage cluster sampling method. The demographic data were collected and weight, height, and waist circumference (WC) were measured, then Body Mass Index (BMI) and Waist-to-Hip ratio were calculated. Overweight and obesity were defined based on WHO reference data. Central obesity was defined as ≥90th percentile of WC. Linear regression an unconditional binary logistic regression were performed to investigate the association between sociodemographic parameters and age at menarche in months, puberty categories, and menarche age groups (<12 vs. ≥12 years) respectively.Results: The prevalence of overweight, obesity, and abdominal fat distribution were 11.5%, 10.3%, and 10.5% respectively. Menarche was experienced by 63% of subjects at the mean age of 12.24±0.98 years. Regression tests revealed that the odds of menarche occurrence at the age of 12 or more was significantly lower in girls with higher BMI (OR: 0.31, 95%CI: 0.22-0.43) than their leaner counterparts (P< 0.001).Conclusion: The findings suggest that being overweight or obese is a possible predictor of experiencing menarche at a younger age.
Fatemeh Sadat Hashemi Javaheri; Hamidreza Kianifar; Pegah Rahbarinejad; Saeedeh Talebi
Abstract
Introduction:Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by difficulties with social interaction and communication, and by restricted and repetitive behavior. Children with ASD are at risk of nutritional problems that could impact growth and anthropometric indices over ...
Read More
Introduction:Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by difficulties with social interaction and communication, and by restricted and repetitive behavior. Children with ASD are at risk of nutritional problems that could impact growth and anthropometric indices over both the short and long term. The aim of present study was to determine prevalence of malnutrition and other factors related to the malnutrition among children and adolescent with autism disorder.Material and method:To assess the prevalence of malnutrition indicators among preschool children with ASD, a cross-sectional study was conducted among 81 children and adolescents who referred to subspecialized and specialized Autism Akbar Children‘s Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. Weight and height measurements were assessed based on standard protocols. The z-score of anthropometric indices was determined for all participants. Participants were asked about nutritional problems by the interview from their parents. Result:In the current study, the mean ± SD of age was 10.1±3.7 years old. Among participants 3.7% were with Diarrhea, 33.3% with Constipation, 4.9% with Reflux, 3.7% with Flatulence, and 1.2% with Steatorrhea. The prevalence of both of food neophobia and food Allergy was 16%. Furthermore, 18.5% had poor appetite, 23.5% had moderate and 58% had good appetite. Based on standardized z-scores, the overall prevalence of under-weight, risk of overweight, overweight, and obese was 1.2%, 22.2%, 12.3%, and 7.4%, respectively. Among participants 4.9% was stunting.Conclusion:Based on aforementioned prevalence, improving nutritional problems and anthropometric indices among ASD children and adolescents are crucial issue.
Ubaid Khan; Behdad Dehbandi; Hafiz Muhammad Waqas Siddique; Muhammd Farhan Akhtar; Zabeeh Ullah
Abstract
Recent clinical research studies evaluated metformin's potential effects as a weight-reducing drug in non-diabetic individuals despite its glucose-lowering effects. Metformin reduces weight by acting on the appetite regulatory pathways, peripheral fat metabolism, and averse unfavorable fat storage. Clinical ...
Read More
Recent clinical research studies evaluated metformin's potential effects as a weight-reducing drug in non-diabetic individuals despite its glucose-lowering effects. Metformin reduces weight by acting on the appetite regulatory pathways, peripheral fat metabolism, and averse unfavorable fat storage. Clinical recent findings indicated that individuals maintain weight with the help of lifestyle modifications and bariatric surgery. However, metformin's clinical efficacy on weight loss helped the individuals overcome overweight and obesity complications. Metformin alters the hypothalamic physiology, including insulin and leptin sensitivity. Furthermore, metformin regulates the circadian rhythm changes and gastrointestinal physiology by affecting food intake and regulating fat oxidation, storage fat in the liver, muscles, and adipose tissues. Research also indicated other appetite suppressing medications such as topiramate, lorcaserin, and phentermine along with metformin also seems logical but clinical data reported that their weight loss results are lacking. However, more detailed research on how metformin induces weight loss in non-diabetic individuals and the prescription of other pharmacological interventions is needed.
Vahideh Banazadeh; Ali Jangjoo; Andisheh Norouzian Ostad; Golnaz Ranjbar; Mahdi Jabbari Noghabi; Daryoush Hamidi Alamdari; Majid Ghayour Mobarhan; Reyhaneh Faridnia; Mohsen Nematy
Abstract
Introduction:Gastric bypass surgery is an intervention used to treat class III obesity and its complications. Evidence is scarce regarding its benefits among the Iranian population, especially its role in resolving obesity-related complaints and comorbidities. The present study aimed to investigate the ...
Read More
Introduction:Gastric bypass surgery is an intervention used to treat class III obesity and its complications. Evidence is scarce regarding its benefits among the Iranian population, especially its role in resolving obesity-related complaints and comorbidities. The present study aimed to investigate the impact of gastric bypass surgery on the improvement of obesity-related complaints and comorbidities in morbid obesity. Methods:This study was conducted on 35 morbidly obese patients who volunteered to undergo gastric bypass surgery. Anthropometric data, comorbidity status, and dietary habits were collected at baseline and six months postoperatively. Data analysis was performed in SPSS version 16.0. Results: The majority of the patients were female (80%). A significant difference was observed in the frequency distribution of normal dietary habits (five regular meals per day) before and after surgery (P = 0.01). In comparison, the distribution was not significant for snacking and three large meals per day (P > 0.05). All complaints of eating disorders according to self-reports (e.g., overeating and night eating syndrome) significantly improved (P < 0.05 ). Moreover, the dose of the medications prescribed for the comorbidities associated with obesity reduced significantly (P = 0.001). The frequency of several obesity-related complaints (e.g., knee pain, hirsutism, acanthosis nigricans, and sleep apnea) also decreased significantly (P < 0.05). However, no significant improvement was observed in hair loss, brittle nails, and menstrual dysfunction (P > 0.05). Conclusion: Accordingly, gastric bypass surgery could improve obesity-related complaints six months postoperatively. Also, according to the patients’ self -declaration, patients’ adherence to “normal eating habits” increased during this period, and their eating disorders like night eating syndrome (NES) and overeating behaviors decreased compared to before the surgery.
Mohamadreza Farzanehfar; Homeyra Ommati; Raheleh Jabini; Mahdi Zardadi
Abstract
This study aimed to describe the case of a young woman presenting with abdominal pain, nausea, and vomiting three month after intragastric balloon placement. The patient was diagnosed with acute pancreatitis based on clinical findings, laboratory data, and imaging results. During endoscopy, the balloon ...
Read More
This study aimed to describe the case of a young woman presenting with abdominal pain, nausea, and vomiting three month after intragastric balloon placement. The patient was diagnosed with acute pancreatitis based on clinical findings, laboratory data, and imaging results. During endoscopy, the balloon was dislodged and obstructed in the second portion of the duodenum. After the removal of the balloon, all the symptoms of the patient were resolved, and she was discharged.